Global Allergy Immunotherapy Market: Rise in Awareness Regarding Allergy Treatment to Boost Market Growth +

Allergy Immunotherapy market information, by allergy type (allergic rhinitis, allergic asthma, peanut allergy, cat allergy, and other allergies), by treatment (Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, and Specific Immunotherapy (SIT)) - global forecast till 2023
This report studies the current as well as future prospects of the global allergy immunotherapy market.Stakeholders of the market include companies and intermediaries engaged in the manufacture, commercialization, and provision of immunotherapeutic drugs for treatment of allergy, as well as new players planning to enter the market.
The global allergy immunotherapy market was valued at US$ 1.37 Bn in 2016 and is projected to register a cumulative annual growth rate (CAGR) of 10.7% 2023, according to a new report titled, “Allergy Immunotherapy Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023”, published by Transparency Market Research (TMR) in April 2018. The report states that high prevalence of allergy diseases across the globe, rise in awareness about allergy treatment, increase in funding for clinical research and grants, launch of new therapies, etc. are expected to spur the growth of the global allergy immunotherapy market during the forecast period.
North America and Europe are projected to dominate the global allergy immunotherapy market in the near future, primarily due to the large base of patients suffering from allergy diseases, high clinical R&D budget to address the unmet needs of the market, launch of new therapies, and increase in awareness regarding allergy treatment in these regions. Europe is estimated to dominate the global allergy immunotherapy market by the end of 2023, which can be ascribed to the high prevalence and rise in incidence rate of allergy diseases in the developed countries in the region such as Germany, France, the U.K., and Italy, promising product pipeline, and initiatives undertaken by the government and non-profit organizations to promote awareness regarding allergy diseases. The allergy immunotherapy market in Europe is expected to register a CAGR of more than 11.5% from 2017 to 2023.
Request to View Sample of Report: https://www.algororeports.com/sample-request/global-allergy-immunotherapy-market-2018-by-manufacturers-countries-type-and-application-forecast-to-2023
High prevalence and rise in incidence rate of allergy disorders to fuel the global market
Allergy immunotherapy, also referred to as desensitization or hypo-sensitization, is a medical treatment targeted against different types of allergies. There is an increase in the prevalence of allergy, and pharmacotherapy, by itself, is insufficient to control the rate of occurrence. Allergy immunotherapeutic treatment boosts immunological tolerance as well as alters the course of the disease. According to the American College of Allergy, Asthma & Immunology, it is estimated that allergies are the sixth leading cause of chronic illness in North America. As per Centers for Disease Control and Prevention (CDC), more than 50 million Americans experience different types of allergies every year. Immunotherapy treatment can help reduce allergy symptoms in around 85% of the people suffering from allergic rhinitis. As per the European Academy of Allergy and Clinical Immunology (EAACI), in 2014, more than 150 million people in Europe are suffering from chronic allergic disorders and it has been estimated that by 2025, over 50% of the population in the region will be affected with allergy diseases. According to the World Allergy Organization (WAO), in 2010, around 30% of the global population suffered from allergic rhinitis. The rapidly growing patient pool, coupled with launch of new therapies and increasing awareness regarding allergy treatment, is projected to drive the allergy immunotherapy market during the forecast period.
Download PDF Brochure of Report: https://www.algororeports.com/sample-request/global-allergy-immunotherapy-market-2018-by-manufacturers-countries-type-and-application-forecast-to-2023
Key Findings:
• Allergic Rhinitis segment accounts for the largest market share in the global Allergy Immunotherapy market while peanut allergy segment is projected to grow at a CAGR of 11.30% during the forecast period from 2017 – 2023.
• Subcutaneous Immunotherapy (SCIT) segment accounts for the largest market share in the global Allergy Immunotherapy market by treatment, this segment is expected to reach US$ 2,089.2 in 2023
• Americas market is expected to reach US$ 1,409.6 by 2023
Intended Audience:
• Allergy Immunotherapy drugs manufacturers
• Allergy Immunotherapy drugs and therapy providers
• Medical research laboratories
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers
• Potential Investors
The global allergy immunotherapy market has been segmented based on treatment type, allergy type, distribution channel, and region.In terms of treatment type, the market has been classified into subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT).
Based on allergy type, the global allergy immunotherapy market has been categorized into allergic rhinitis, asthma, food allergy, venom allergy, and others. In terms of distribution channel, the market has been divided into hospital pharmacies, retail pharmacies & drug stores, and online pharmacies.
Each of the market segments has been extensively analyzed based on market-related factors such as increase in incidence and prevalence of allergy.Moreover, historical year-on-year growth has been taken into consideration while estimating the market size.
The market overview section of the report explores the market dynamics such as drivers, restraints, opportunities, and pipeline drugs that currently have a strong impact on the allergy immunotherapy market and are likely to influence the market in the near future.Market attractiveness analysis has been provided in the overview section in order to explain the intensity of competition in the market across different regions.

Request for Discount on This Report: https://www.algororeports.com/check-discount/global-allergy-immunotherapy-market-2018-by-manufacturers-countries-type-and-application-forecast-to-2023
The global allergy immunotherapy market has been segmented as follows:
By Treatment Type
• SCIT (Subcutaneous Immunotherapy)
• SLIT (Sublingual Immunotherapy)
By Allergy Type
• Allergic Rhinitis
• Asthma
• Food Allergy
• Venom Allergy
• Others
By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Drug Stores
• Online Pharmacy
By Region
• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia & New Zealand
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• GCC
• South Africa
• Israel
• Rest of Middle East & Africa

Key players for global Allergy Immunotherapy market:
Some of the key players in this market are: ALK Abello A/S (Denmark), Allergy Therapeutics (UK), Circassia (UK), DBV Technologies (France), Stallergenes Greer (UK), Merck KGaA (Allergopharma) (Germany), HAL Allergy Group (Netherlands), and others.

The report for Global Allergy Immunotherapy Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions.
Get your Full report Access Here: https://www.algororeports.com/reports/global-allergy-immunotherapy-market-2018-by-manufacturers-countries-type-and-application-forecast-to-2023

AlgoroReports is a part of Algororesearch Consultant Pvt. Ltd. AlgoroReports is one of the largest collections of market research reports from numerous publishers with the team of industries specialist that meet with best client requirements. Market Research is based on a research project that may also be an expansion on past work in the field. Research projects can be used to develop further knowledge on a topic, geography, culture, linguistics, and community to provide exact idea about existing market.

Neel Patel
Manager Business Development
www.algororeports.com
neel.patel@algororeports.com
Ph: +1–972–591–8785 (US)
info@algororeports.com

This release was published on openPR.